Université de Strasbourg and partners report that adding structural variants and small insertion–deletion mutations to single ...

Researchers create an artificial genetic system mimicking reverse translation, converting music into DNA to explore ...

Genomics unveils Mystra at ASHG 2025—an AI genetics platform to accelerate drug discovery and clinical validation using large-scale genetic data.

Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic ...

Please provide your email address to receive an email when new articles are posted on . This analysis examined three phenotypes of pulmonary hypertension (PH) associated with COPD. Patients with ...

Please provide your email address to receive an email when new articles are posted on . The FDA based mepolizumab’s approval on phase 3 MATINEE and METREX trial results. Mepolizumab has been assessed ...

Mepolizumab targets IL-5, addressing eosinophilic inflammation in 20%-40% of COPD patients, marking its fifth US indication. The phase 3 MATINEE trial showed a 21% reduction in annualized moderate or ...

Diabetes is on the rise in India, and the numbers are staggering: over 101 million people are already living with it, and the count is only going up 1. However, the surprising part is how diabetes ...